Djupsjo Catarina, Sartipy Ulrik, Ivert Torbjorn, Karayiannides Stelios, Lundman Pia, Nystrom Thomas, Holzmann Martin J, Kuhl Jeanette
Medicine, Karolinska Institute, Stockholm, Stockholm County, Sweden.
Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Stockholm County, Sweden.
Open Heart. 2020 Jun;7(1). doi: 10.1136/openhrt-2019-001217.
Disturbances of glucose metabolism are important risk factors for coronary artery disease and are associated with an increased mortality risk. The aim was to investigate the association between preoperative disturbances of glucose metabolism and long-term all-cause mortality after coronary artery bypass grafting (CABG).
Patients undergoing a first isolated CABG in 2005-2013 were included. All patients without previously known diabetes underwent an oral glucose tolerance test (OGTT) before surgery. They were categorised as having normal glucose tolerance (NGT), pre-diabetes (impaired glucose tolerance and/or impaired fasting glucose) or newly discovered diabetes. Data were collected from nationwide healthcare registers. Cox regression was used to calculate adjusted HR with 95% CI for death in patients with pre-diabetes and diabetes, using NGT as reference.
In total, 497 patients aged 40-86 years were included. According to OGTT, 170 (34%) patients had NGT, 219 (44%) patients with pre-diabetes and 108 (22%) patients had newly discovered diabetes. Baseline characteristics were similar between the groups except for slightly higher age among patients with newly discovered diabetes. There were 133 (27%) deaths during a mean follow-up time of 10 years. The cumulative 10-year survival was 77% (69%-83%), 83% (77%-87%) and 71% (61%-79%) in patients with NGT, pre-diabetes and newly discovered diabetes, respectively. There was no significant difference in all-cause mortality between the groups after multivariable adjustment.
In this study, patients with pre-diabetes or newly discovered diabetes prior to CABG had similar long-term survival compared with patients with NGT.
糖代谢紊乱是冠状动脉疾病的重要危险因素,且与死亡风险增加相关。目的是研究冠状动脉旁路移植术(CABG)术前糖代谢紊乱与长期全因死亡率之间的关联。
纳入2005年至2013年首次接受单纯CABG的患者。所有既往无糖尿病的患者在手术前均接受口服葡萄糖耐量试验(OGTT)。他们被分类为糖耐量正常(NGT)、糖尿病前期(糖耐量受损和/或空腹血糖受损)或新发现糖尿病。数据从全国医疗保健登记处收集。使用Cox回归计算糖尿病前期和糖尿病患者死亡的调整后HR及95%CI,以NGT作为对照。
总共纳入了497例年龄在40 - 86岁之间的患者。根据OGTT,170例(34%)患者糖耐量正常,219例(44%)患者为糖尿病前期,108例(22%)患者为新发现糖尿病。除新发现糖尿病患者年龄略高外,各组间基线特征相似。在平均10年的随访期内有133例(27%)死亡。NGT、糖尿病前期和新发现糖尿病患者的10年累积生存率分别为77%(69% - 83%)、83%(77% - 87%)和71%(61% - 79%)。多变量调整后各组间全因死亡率无显著差异。
在本研究中,CABG术前糖尿病前期或新发现糖尿病的患者与糖耐量正常的患者具有相似的长期生存率。